Bethesda, MD (July 9, 2019) — The National Foundation for Infectious Diseases (NFID) is pleased to announce the election of Monica M. Farley, MD, of Emory University School of Medicine in Atlanta, GA, and the re-election of Lisa S. Ipp, MD, of Weill Cornell Medicine, New York-Presbyterian to the NFID Board of Directors.
Dr. Farley is a professor of medicine at Emory, director of the Division of Infectious Diseases, and a staff physician at the Atlanta VA Medical Center. She is a past president of both the American Federation for Medical Research and the Southern Society for Clinical Investigation, as well as a previous member of the Food and Drug Administration Advisory Committee on Vaccines and Related Biological Products. She serves as the principal investigator for the Georgia Emerging Infections Program (EIP), a Centers for Disease Control and Prevention(CDC)-funded surveillance network of epidemiologic and clinical research groups focused on invasive bacterial pathogens, influenza, and foodborne diseases. Her research program provides a population-based assessment of the epidemiology and risk factors for a number of important bacterial infections, including pneumococcal disease, Clostridioides difficile infections, and community-associated MRSA disease. Since 2005, Dr. Farley has served as co-chair of the NFID Clinical Vaccinology Course and she presented the Robert Austrian Memorial Lecture at the 2019 NFID Annual Conference on Vaccinology Research.
“I have been involved with NFID for many years and have developed a strong appreciation for the organization and its mission to educate the public and healthcare professionals about the burden, causes, prevention, diagnosis, and treatment of infectious diseases across the lifespan,” said Dr. Farley. “It is an honor to serve on the Board of Directors so that I can more directly contribute to the important activities of NFID.”
Dr. Ipp is an associate professor in pediatrics at Weill Cornell Medicine, an associate attending pediatrician in the Department of Pediatrics at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and the chief of Pediatric Medicine at Hospital for Special Surgery. She is board-certified in pediatrics and adolescent medicine, and is a member of the American College Health Association, the American College of Obstetricians and Gynecologists, and the Society for Adolescent Health and Medicine. Dr. Ipp has received special training in sexual assault evaluation, addiction medicine, and child/adolescent psychiatry. She is the author of many articles pertaining to adolescent health and was the principal investigator for an NFID study on motivating college students to receive annual influenza vaccines.This is her second three-year term on the NFID Board.
“As a healthcare community, we have long known that college students and other young people are profoundly under-vaccinated,” said Dr. Ipp. “I am eager to continue working with colleagues at NFID to share important insights and best practices to increase immunization rates and drive overall improvements in public health.”
The NFID Board of Directors also expresses appreciation to outgoing Director Ruth M. Carrico, PhD, RN, CIC, associate professor and family nurse practitioner at the University of Louisville School of Medicine, Division of Infectious Diseases.
The NFID Executive Committee includes Joseph A. Bocchini, Jr., MD, Louisiana State University Health Sciences Center, President; Walter A. Orenstein, MD, Emory Vaccine Center, Immediate Past-President; Kevin Rooney, Beacon Consulting Group, Treasurer; Patricia A. Stinchfield, RN, MS, CPNP, CIC, Children’s Minnesota, Vice President; H.Keipp B.Talbot, MD, MPH, Vanderbilt University School of Medicine, Secretary; and Patricia N. Whitley-Williams, MD, Rutgers Robert Wood Johnson Medical School, President-Elect.
Additional members of the 2019-2020 NFID Board of Directors are listed below. As the governing body, the Board of Directors establishes the strategic direction for NFID, ensures that annual goals are met, and provides financial oversight.
Beth P. Bell, MD, MPH, Centers for Disease Control and Prevention (Retired)
Cristina Cassetti, PhD, National Institute of Allergy and Infectious Diseases, National Institutes of Health, NFID Federal Liaison
Sara E. Cosgrove, MD, Johns Hopkins University School of Medicine
RichardJ.Duma, MD, PhD, NFID Director Emeritus
Jeffery A. Goad, PharmD, MPH, Chapman University School of Pharmacy
Ruth Lynfield, MD, Minnesota Department of Health
Kathleen M. Neuzil, MD, MPH, Center for Vaccine Development, University of Maryland School of Medicine
Cynthia Pellegrini, March of Dimes
William Schaffner, MD (Ex-Officio), NFID Medical Director
Marla Dalton, PE, CAE (Ex-Officio), NFID Executive Director and CEO
About the National Foundation for Infectious Diseases
Founded in 1973, the National Foundation for Infectious Diseases (NFID) is a non-profit 501(c)(3) organization dedicated to educating the public and healthcare professionals about the burden, causes, prevention, diagnosis, and treatmentof infectious diseases across the lifespan. Visit www.nfid.org for more information.
Contact: Diana Olson at 301-656-0003 x140
Recent Press Releases
NFID to Honor 3 Public Health Heroes with 2025 Awards
Public health heroes will be honored at a black-tie fundraising event in October 2025 in Washington, DC
National Foundation for Infectious Diseases Announces 2025-2026 Board of Directors
NFID announces the appointment of an esteemed group of leaders serving as the 2025-2026 NFID Board of Directors
Statement on June 2025 Advisory Committee on Immunization Practices Meeting
NFID strongly supports the use of evidence-based guidance reviewed by qualified experts, within CDC and externally, to inform public health policy, and will work to protect the health of people across the US …